<- Go home

Added to YB: 2021-11-01

Pitch date: 2021-11-01

TELA:US [bullish]

TELA Bio, Inc.

-91.45%

current return

Author Info

No bio for this author

Company Info

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s anatomy.

Market Cap

$39.6M

Pitch Price

$13.34

Price Target

N/A

Dividend

N/A

EV/EBITDA

-1.51

P/E

-1.12

EV/Sales

0.67

Sector

Health Care Equipment and Supplies

Category

N/A

Show full summary:
TELA Bio, Inc. TELA:US

A summary for this pitch has not been created yet.

Read full article (0 min)